The frequency of EGFR mutations is higher in Asian than Caucasian populations; in Japanese NSCLC patients, the prevalence of EGFR mutations has been reported to be approximately 30–40% [1]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.